Cholangiocarcinoma: novel therapeutic targets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholangiocarcinoma: novel therapeutic targets

Published:2020-02-26 Issue:4 Volume:24 Page:345-357
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Sato Keisaku¹,Glaser Shannon²,Alvaro Domenico³,Meng Fanyin¹⁴,Francis Heather¹⁴,Alpini Gianfranco¹⁴

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

2. Department of Medical Physiology, Texas A&M University, College of Medicine, Bryan, Texas

3. Gastroenterology, Medicine, Università Sapienza, Rome, Italy

4. Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1733528

Reference130 articles.

1. Cholangiocarcinoma: a guide for the nonspecialist

2. Cholangiocarcinoma

3. Epidemiology and Risk Factors of Cholangiocarcinoma

4. Cholangiocarcinoma

5. Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase;Current Medicinal Chemistry;2024-08

2. Role of miRNA‑122 in cancer (Review);International Journal of Oncology;2024-07-18

3. MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis;ASSAY and Drug Development Technologies;2024-07-01

4. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination;Biology Direct;2024-02-23

5. Targeting polycomb repressor complex 2‐mediated bivalent promoter epigenetic silencing of secreted frizzled‐related protein 1 inhibits cholangiocarcinoma progression;Clinical and Translational Medicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3